Catalyst Wire Dossier Catalyst Wire Dossier

recombinant and protein-free Factor VIII (rAHF-PFM)

rAHF-PFM · Baxalta (now part of Shire)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for recombinant and protein-free Factor VIII (rAHF-PFM), covering 2021-08-24 to 2021-08-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery [Phase 2, Phase 3]

See pricing